OR WAIT null SECS
November 17, 2021
Exploring the FDA’s latest proposed guidance on computer system validation, and the movement toward a less burdensome approach
November 12, 2021
White House announces official endorsement, paving way for Senate confirmation process
It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates
November 02, 2021
Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023
October 20, 2021
As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits
October 14, 2021
Exploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US
October 08, 2021
The pandemic has accelerated the adoption of enterprise resource planning in pharma supply chain management, as the recent US rise of one “technology enabler” attests
October 05, 2021
A dramatic shift to e-sampling has been the effective counter to the reduced number of rep visits to physicians’ offices
September 27, 2021
Recent FDA actions may finally usher in access boost to follow-on biologics in the US
September 13, 2021
FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance
